Skip to main content
. 2018 Mar 12;118(7):966–971. doi: 10.1038/s41416-018-0021-1

Fig. 1.

Fig. 1

Objective tumour responses with everolimus. Waterfall plot of the maximum percentage change in target lesions compared with baseline measurements. Three patients achieved a partial response. Four patients had a 0% change in tumour burden. The dotted line denotes a 30% reduction in target lesions